Ola Landgren, MD, PhD, is the chief of the myeloma division and leader of the experimental therapeutics program at Sylvester Comprehensive Cancer Center at the University of Miami Health System. He is also a professor of medicine at the University of Miami.
Advancing Care, Addressing Ongoing Challenges at the EHA 2025 Congress: Ola Landgren, MD, PhD
Ahead of the 30th European Hematology Association (EHA) Congress in Milan, Ola Landgren, MD, PhD, shares what he is most looking forward to and reflects on key advancements and ongoing challenges in hematology.